CRVO
CervoMed Inc.Company Information
- Company Name
- CervoMed Inc.
- CIK
- CIK0001053691
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CRVO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CRVO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-11
- Last sale
- 2024-02-26
- Shares purchased (TTM)
- 1,009,020
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,723,078
- Shares outstanding
- 10,244,516
- Ownership
- 16.82%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -9.41%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 22 | 8 | 8 | 9 | 8 | 11 | 9 | 8 | 10 | 6 | 8 | 10 | ||||||
| Marketable Securities Current | 2 | 5 | 13 | 18 | 25 | 25 | 30 | 39 | 35 | - | 0 | - | ||||||
| Deferred Offering Costs | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | 0 | - | - | ||||||
| Grants Receivable Current | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | - | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 26 | 15 | 23 | 31 | 38 | 39 | 43 | 49 | 47 | 8 | 10 | 12 | ||||||
| Marketable Securities Noncurrent | - | - | - | - | - | - | - | - | 6 | - | - | - | ||||||
| Assets | 26 | 15 | 23 | 31 | 38 | 39 | 43 | 49 | 53 | 8 | 10 | 12 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | 1 | 1 | - | 1 | ||||||
| Other Accrued Liabilities Current | - | - | 3 | - | - | 2 | 2 | 2 | 1 | 1 | 2 | 1 | ||||||
| Liabilities Current | - | - | 5 | - | - | - | 4 | - | - | - | - | - | ||||||
| Liabilities | 3 | 4 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 135 | 116 | 116 | 116 | 115 | 110 | 110 | 110 | 109 | 62 | 62 | 62 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -112 | -106 | -98 | -90 | -82 | -76 | -71 | -64 | -59 | -57 | -54 | -52 | ||||||
| Stockholders Equity | 23 | 11 | 18 | 26 | 33 | 35 | 39 | 46 | 50 | 5 | 7 | 10 | ||||||
| Liabilities And Stockholders Equity | 26 | 15 | 23 | 31 | 38 | 39 | 43 | 49 | 53 | 8 | 10 | 12 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0.00 | - | - | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | 30 | - | 30 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Shares Outstanding | 14 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 6 | 6 | 6 | ||||||
| Common Stock Shares Issued | 14 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 6 | 6 | 6 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCervoMed Inc. (CRVO) — SEC Financial Statements & Analysis
CervoMed Inc. (CRVO) is a pharmaceutical preparations company, incorporated in DE. CervoMed Inc. trades on Nasdaq as: CRVO. CervoMed Inc. (CRVO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, CervoMed Inc. carries a market cap of $31.76M, a P/E ratio of -1.05x, a P/B ratio of 1.38x, a P/S ratio of 95.86x, an enterprise value of $9.30M, and an EV/EBITDA multiple of -0.30x. On profitability, it posts an operating margin of -9406.96%, a net margin of -9160.94%, a Return on Equity (ROE) of -107.62%, a Return on Assets (ROA) of -94.73%, and a Return on Invested Capital (ROIC) of -241.78%. Per share, it reports EPS of $-2.96, diluted EPS of $-1.27, free cash flow per share of $-2.73, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -95.74% year-over-year, net income growth of 34.22% year-over-year, and EPS growth of 17.27% year-over-year. On the balance sheet, it maintains a current ratio of 4.91x, a quick ratio of 4.91x, working capital of $18.22M, a debt-to-equity ratio of 0.26x, a debt ratio of 0.2, an interest coverage ratio of -50.05x, free cash flow of $-27.98M (TTM), and net debt of $-22.46M. Figures sourced from SEC EDGAR.
- Market Cap
- $31.76M
- P/E TTM
- -1.05x
- EPS TTM
- $-2.96
- P/B TTM
- 1.38x
- ROE TTM
- -107.62%
- ROA TTM
- -94.73%
- Debt To Equity
- 0.26x
- Free Cash Flow TTM
- $-27.98M
- Net Revenue TTM Growth 1Y
- -95.74%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CervoMed Inc. in?
CervoMed Inc. (CRVO) operates in the Pharmaceutical Preparations industry.
What exchange does CRVO trade on?
CervoMed Inc. (CRVO) trades on the Nasdaq.
Where is CervoMed Inc. incorporated?
CervoMed Inc. is incorporated in DE.
When was CervoMed Inc. (CRVO)'s most recent SEC filing?
CervoMed Inc. (CRVO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is CRVO's market cap?
CervoMed Inc. (CRVO) has a market capitalization of $31.76M as of 2026-06-30.
What is CRVO's EPS (earnings per share)?
CervoMed Inc. (CRVO)'s trailing twelve month EPS is $-2.96 as of 2026-06-30.
What is CRVO's ROE (return on equity)?
CervoMed Inc. (CRVO)'s trailing twelve month Return on Equity (ROE) is -107.62% as of 2026-06-30.
What is CRVO's ROA (return on assets)?
CervoMed Inc. (CRVO)'s trailing twelve month Return on Assets (ROA) is -94.73% as of 2026-06-30.
What is CRVO's ROIC (return on invested capital)?
CervoMed Inc. (CRVO)'s trailing twelve month Return on Invested Capital (ROIC) is -241.78% as of 2026-06-30.
What is CRVO's EV/EBITDA?
CervoMed Inc. (CRVO)'s trailing twelve month EV/EBITDA is -0.30x as of 2026-06-30.